Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry synopsis, 2021-2034
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.1.1 Factor affecting the value chain
3.1.2 Profit margin analysis
3.1.3 Disruptions
3.1.4 Future outlook
3.1.5 Manufacturers
3.1.6 Distributors
3.2 Supplier landscape
3.3 Profit margin analysis
3.4 Key news & initiatives
3.5 Regulatory landscape
3.6 Impact forces
3.7 Industry impact forces
3.7.1 Growth drivers
3.7.1.1 Growing trends towards cigarette smoking and exposure to tobacco smoke leading to increase in COPD
3.7.1.2 Exposure to polluted air quality leading to development of serious medical conditions like bronchitis
3.7.1.3 Pharmaceutical market expansion
3.7.2 Market challenges
3.7.2.1 Limitation of the drug with certain medical condition
3.8 Regulations & market impact
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix
Chapter 5 Market Size and Forecast, By Application, 2021-2034 (USD Million) (Tons)
5.1 Key trends
5.2 Bronchitis
5.3 COPD
5.4 Nasopharyngitis
5.5 Others
Chapter 6 Market Size and Forecast, By End Use, 2021-2034 (USD Million) (Tons)
6.1 Key trends
6.2 Pharmaceutical
6.3 CMOs
6.4 Research institutes
Chapter 7 Market Size and Forecast, By Region, 2021-2034 (USD Million) (Tons)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 UK
7.3.2 Germany
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Russia
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 South Korea
7.4.5 Australia
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.6 MEA
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
Chapter 8 Company Profiles
8.1 Apotex Inc.
8.2 Cipla Ltd.
8.3 Dr. Reddy's Laboratories
8.4 Hanmi Pharmaceutical
8.5 Hikma Pharmaceuticals
8.6 Mylan N.V.
8.7 Recipharm AB
8.8 Sandoz
8.9 Shandong Luoxin Pharmaceutical
8.10 Zhejiang Kangle Pharmaceutical Co., Ltd
